Priority Medicines for Europe and the World

"A Public Health Approach to Innovation"

 

Annexes to Section 8.1

Public Private Partnerships for Neglected Diseases

Case study 1  Medicines for Malaria Venture (MMV) [doc 151KB]

Case study 2  Drugs for Neglected Diseases (DNDi)   [doc 205KB]

Case study 3  Global Alliance for Tuberculosis Research (TB Alliance)  [doc 235KB]

Case study 4  International AIDS Vaccine Initiative (IAVI) [doc 429KB]


 

8.1.1 Legislation and Regulations defining "Rare Diseases" and "Orphan Drugs" [doc 35KB]

 

8.1.2 Introduction: Summary of Major Public-Private Partnerships for Neglected Diseases [doc 26KB]

A.  Table of Public-Private Partnerships [xls 42KB]

B.  Public-Private Partnerships Receiving Direct Grant from Gates Foundation [xls 17KB]

C.  Partnership Summaries [doc 454KB]

D.  Gates Foundation Funding to Program for Appropriate Technologies in Health (PATH) [xls 16KB]

 

8.1.3  Key Personnel for Case Study Organizations [doc 426KB]

 

8.1.4  A summary of the AIDS Pandemic by Geographical Region [doc 58KB]